Developer docs
API playgroundTry for free, no card

Search company profiles

CarMeN Laboratory INRAE UMR1397-INSERM U1060

Full company profile

uuid00436zp

Namestring
CarMeN Laboratory INRAE UMR1397-INSERM U1060
Legal namestring
Laboratoire CarMeN - Cardiovasculaire, Métabolisme, Diabète et Nutrition
Company typeenum
Private
Founded yearint
2011
Descriptiontext

CarMeN Laboratory (INSERM U1060 / INRAE U1397 / Université Claude Bernard Lyon 1) is a public, non-profit biomedical research unit (Unité Mixte de Recherche) created in Lyon in January 2011 and jointly supervised by INSERM, INRAE, Université Lyon 1, and Hospices Civils de Lyon. It is dedicated to research on cardiovascular disease, metabolism, diabetes, and nutrition, organized into three research teams (DO-IT, MERISM, IRIS) plus a support team, operating across two sites: Lyon Sud Hospital (Pierre-Bénite) and Groupement Hospitalier Est (Bron).

The laboratory maintains six specialized technical platforms — Cytometry, Genomics, Histology, Ixplora (in vivo exploration), Microscopy, and the ISO 9001:2015-certified CarMeN Biobank — and an affiliated clinical research platform, CRNH Rhône-Alpes, which conducts human nutrition studies and recruits voluntary participants. Core technology comprises advanced confocal and live-cell imaging systems (Nikon A1R+, Leica, IonOptix), cryopreservation infrastructure (11 LN₂ tanks, 15 -80°C freezers), and a biological sample repository spanning human and animal specimens collected since founding.

CarMeN does not commercialize products. Funding flows from French public research institutions (INSERM, INRAE, Université Lyon 1, Hospices Civils de Lyon) and competitive national/European grants (ANR, ERA4Health). The CRNH platform generates in-kind research output (clinical nutrition studies with voluntary participants indemnified €150–€600 per study) rather than commercial revenue. Outputs are disseminated through peer-reviewed publications (Lancet, Gut, Kidney International, Nature Cell Biology, J. Extracell. Vesicles), conference presentations, and educational programs including the MuSkLE Summer School.

Short descriptiontext

CarMeN Laboratory is a French public biomedical research unit (INSERM U1060 / INRAE U1397 / Université Lyon 1) dedicated to cardiovascular, metabolic, diabetes, and nutrition research, operating three teams and six technical platforms across two Lyon-area hospital sites.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersPierre-Bénite, France
HQ citystring
Pierre-Bénite
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biomedical research laboratory, cardio-metabolic research, clinical nutrition studies, cardiovascular disease research, diabetes metabolism research
Industry1 code
1Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
CodeHLAGAAALPrimaryYes
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Biomedical Research Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Public Research Funding
TypeLicensing Royalties
Description

Funded through institutional affiliations with INSERM, INRAE, and Université Lyon 1. Receives grants from national research agencies and participates in European funding programs (ERA4Health). Revenue comes from public research financing rather than commercial operations.

carmen.univ-lyon1.fr
2Clinical Research Services
TypeProfessional Services
Description

Conducts clinical nutrition studies through the Centre de Recherche en Nutrition Humaine Rhône-Alpes (CRNH-RA) platform. Studies are authorized by CPP ethics committees and ANSM, and may receive public research funding.

carmen.univ-lyon1.fr
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Infrastructure, Operations
Pricing details1 tier
1Volunteer compensation for clinical nutrition studies
ModelUnit PricingBilling cadenceOne time
Notes

Glymicare study: 600 euros compensation. Expem probiotic study: 300 euros + 50 euros travel. Sensilins sensory study: 150 euros + transport allowance up to 50 euros. Part'AGE study: no specific compensation mentioned. Travel and parking expenses generally reimbursed.

carmen.univ-lyon1.fr
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

CarMeN is a French biomedical research laboratory conducting fundamental and translational research on cardiovascular diseases, metabolism, diabetes, and nutrition. It operates three research teams (DO-IT, MERISM, IRIS) and provides access to six specialized technical platforms (cytometry, genomics, histology, Ixplora, microscopy, and biobank). The affiliated CRNH Rhône-Alpes clinical research platform conducts human nutrition studies and recruits volunteers, while the laboratory maintains ISO 9001:2015 certified quality management.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 10th consecutive ISO 9001:2015 certification achieved in June 2023, demonstrating sustained quality management over 10+ years
+3 more records
Product overview1 text field

CarMeN Laboratory is a biomedical research institution (INSERM U1060/INRAE U1397/Université Lyon1) dedicated to research in cardiovascular disease, metabolism, diabetes, and nutrition. The laboratory operates three research teams (DO-IT focusing on food and intestinal therapeutics for obesity, MERISM focusing on mitochondria-ER interactions in metabolic diseases, and IRIS focusing on ischemia-reperfusion syndromes) and provides access to six technical platforms (Cytometry, Genomics, Histology, Ixplora, Microscopy, and Biobank). The affiliated CRNH Rhône-Alpes Clinical Research Platform conducts human nutrition studies and recruits volunteers for health nutrition research.

Product and service1 record
1Cytometry Platform
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
1IHU Everest
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-02-01
Description

Institute hosting the symposium on Hepatic Organoids & Ex Vivo 3D Models organized by Jennifer Rieusset at Lyon Sud. Collaborative platform for liver research using organoid and 3D model technologies.

carmen.univ-lyon1.fr
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-11-01
Description

Franco-Brazilian research collaboration through CAPES-COFECUB project coordinated by Prof. Marciane Magnani, partnering with Prof. Hubert Vidal on probiotic and prebiotic research.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-10-01
Description

Franco-Brazilian cooperation through CAPES-COFECUB project on translational evaluation of probiotics and prebiotics. Hosting of Prof. Carol Gois Leandro for collaborative seminar on VITORIA project (obesity reduction in adolescents).

Strategic tierMinorTypeOthersAnnounced on2024-05-01
Description

Hosted Prof. Benoît Arsenault for seminar on body weight and health research. Researcher at Institut de cardiologie et de pneumologie du Québec focusing on cardiometabolic risk markers and lifestyle modification interventions.

5INSERM U1060
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2011-01-01
Description

Institut national de la santé et de la recherche médicale - primary institutional affiliation providing research framework, funding, and personnel oversight. Laboratory created at Lyon in January 2011 under this partnership and renewed in 2016 and January 2021.

carmen.univ-lyon1.fr
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2011-01-01
Description

Institut national de recherche pour l'agriculture, l'alimentation et l'environnement - institutional partner co-managing the laboratory. Part of the joint INSERM U1060/INRAE U1397 structure.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2011-01-01
Description

Université Claude Bernard Lyon 1 - academic partner providing university framework, student training, and research supervision for doctoral programs.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2011-01-01
Description

Public hospital system hosting the laboratory at Lyon Sud Hospital and providing clinical research infrastructure and patient access for cardio-metabolic studies.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical nutrition research platform integrated into the CarMeN laboratory structure, located at Lyon Sud Hospital. Conducts human nutrition studies with authorized clinical research protocols.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Major French non-profit biomedical research institution. Comparable to CarMeN's non-profit public research model, multi-platform structure, and translational publication record, though broader in scope.

TypeBroad incumbent
Description

Leading European medical university conducting biomedical and clinical research including metabolic disease. Comparable to CarMeN in academic research mission, publication output, and clinical-trial execution capability, though operating at much larger scale.

TypeBroad incumbent
Description

France's largest public research organization. Comparable as a parent-equivalent public research framework operating under similar French institutional funding mechanisms and shared laboratory hosting arrangements.

TypeDirect peer
Description

UK-based academic unit focused on metabolic disease mechanisms, sharing CarMeN's cardio-metabolic research mandate and bench-to-clinic translation pathway.

TypeDirect peer
Description

German research institute dedicated to metabolism, obesity, and diabetes research. Highly comparable to CarMeN given the overlapping cardio-metabolic disease focus and basic-to-translational research model, though operating at larger scale.

TypeDirect peer
Description

Canadian cardiovascular research center that hosted CarMeN's collaboration with Prof. Benoît Arsenault. Comparable given overlapping cardio-metabolic risk-marker research and lifestyle intervention clinical studies.

TypeEmerging player
Description

Industry-led nutrition and metabolic health research arm operating with similar cardio-metabolic and nutrition themes. Comparable to CarMeN's translational nutrition research scope but backed by private-sector funding rather than public grants.

TypeDirect peer
Description

Parent-affiliated INRAE unit focused on nutrition research. Closely comparable as a French nutrition research organization sharing CarMeN's INRAE U1397 institutional framework and human nutrition methodology.

TypeDirect peer
Description

French institute focused on liver and metabolic disease organoid/3D-model research. Direct peer given CarMeN's collaboration with IHU Everest on hepatic organoid research and overlapping MASLD/translational focus.

TypeBroad incumbent
Description

French INSERM biomedical research unit. Comparable as a French academic biomedical research organization operating under similar institutional frameworks and grant structures, though its focus is broader and less cardio-metabolic-centric.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CarMeN Laboratory INRAE UMR1397-INSERM U1060

Biomedical Research Servicescarmen.univ-lyon1.fr

CarMeN Laboratory is a French public biomedical research unit (INSERM U1060 / INRAE U1397 / Université Lyon 1) dedicated to cardiovascular, metabolic, diabetes, and nutrition research, operating three teams and six technical platforms across two Lyon-area hospital sites.

What CarMeN Laboratory INRAE UMR1397-INSERM U1060 does

CarMeN Laboratory (INSERM U1060 / INRAE U1397 / Université Claude Bernard Lyon 1) is a public, non-profit biomedical research unit (Unité Mixte de Recherche) created in Lyon in January 2011 and jointly supervised by INSERM, INRAE, Université Lyon 1, and Hospices Civils de Lyon. It is dedicated to research on cardiovascular disease, metabolism, diabetes, and nutrition, organized into three research teams (DO-IT, MERISM, IRIS) plus a support team, operating across two sites: Lyon Sud Hospital (Pierre-Bénite) and Groupement Hospitalier Est (Bron).

The laboratory maintains six specialized technical platforms — Cytometry, Genomics, Histology, Ixplora (in vivo exploration), Microscopy, and the ISO 9001:2015-certified CarMeN Biobank — and an affiliated clinical research platform, CRNH Rhône-Alpes, which conducts human nutrition studies and recruits voluntary participants. Core technology comprises advanced confocal and live-cell imaging systems (Nikon A1R+, Leica, IonOptix), cryopreservation infrastructure (11 LN₂ tanks, 15 -80°C freezers), and a biological sample repository spanning human and animal specimens collected since founding.

CarMeN does not commercialize products. Funding flows from French public research institutions (INSERM, INRAE, Université Lyon 1, Hospices Civils de Lyon) and competitive national/European grants (ANR, ERA4Health). The CRNH platform generates in-kind research output (clinical nutrition studies with voluntary participants indemnified €150–€600 per study) rather than commercial revenue. Outputs are disseminated through peer-reviewed publications (Lancet, Gut, Kidney International, Nature Cell Biology, J. Extracell. Vesicles), conference presentations, and educational programs including the MuSkLE Summer School.

CarMeN Laboratory INRAE UMR1397-INSERM U1060 firmographics

Firmographics
Name
CarMeN Laboratory INRAE UMR1397-INSERM U1060
Legal name
Laboratoire CarMeN - Cardiovasculaire, Métabolisme, Diabète et Nutrition
Website
https://carmen.univ-lyon1.fr
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
51–100 employees
Short description
CarMeN Laboratory is a French public biomedical research unit (INSERM U1060 / INRAE U1397 / Université Lyon 1) dedicated to cardiovascular, metabolic, diabetes, and nutrition research, operating three teams and six technical platforms across two Lyon-area hospital sites.
Ownership category
akta.pro rank

CarMeN Laboratory INRAE UMR1397-INSERM U1060 industry classification

Industry
Product category
Biomedical Research Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)

Keywords

  • Biomedical research laboratory
  • Cardio-metabolic research
  • Clinical nutrition studies
  • Cardiovascular disease research
  • Diabetes metabolism research

Where CarMeN Laboratory INRAE UMR1397-INSERM U1060 is headquartered

Location

Headquarters

HQ city
Pierre-Bénite
HQ country
France
HQ region
Europe

Offices2 records

Markets served

CarMeN Laboratory INRAE UMR1397-INSERM U1060 business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Infrastructure, Operations

Revenue model

  1. Public Research Funding: Funded through institutional affiliations with INSERM, INRAE, and Université Lyon 1. Receives grants from national research agencies and participates in European funding programs (ERA4Health). Revenue comes from public research financing rather than commercial operations.
  2. Clinical Research Services: Conducts clinical nutrition studies through the Centre de Recherche en Nutrition Humaine Rhône-Alpes (CRNH-RA) platform. Studies are authorized by CPP ethics committees and ANSM, and may receive public research funding.

Pricing tiers

ModelBillingPrice
Unit PricingOne timeVolunteer compensation for clinical nutrition studies

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

CarMeN Laboratory INRAE UMR1397-INSERM U1060 product offering

Product offering

Core offering

CarMeN is a French biomedical research laboratory conducting fundamental and translational research on cardiovascular diseases, metabolism, diabetes, and nutrition. It operates three research teams (DO-IT, MERISM, IRIS) and provides access to six specialized technical platforms (cytometry, genomics, histology, Ixplora, microscopy, and biobank). The affiliated CRNH Rhône-Alpes clinical research platform conducts human nutrition studies and recruits volunteers, while the laboratory maintains ISO 9001:2015 certified quality management.

Product overview

CarMeN Laboratory is a biomedical research institution (INSERM U1060/INRAE U1397/Université Lyon1) dedicated to research in cardiovascular disease, metabolism, diabetes, and nutrition. The laboratory operates three research teams (DO-IT focusing on food and intestinal therapeutics for obesity, MERISM focusing on mitochondria-ER interactions in metabolic diseases, and IRIS focusing on ischemia-reperfusion syndromes) and provides access to six technical platforms (Cytometry, Genomics, Histology, Ixplora, Microscopy, and Biobank). The affiliated CRNH Rhône-Alpes Clinical Research Platform conducts human nutrition studies and recruits volunteers for health nutrition research.

Differentiator

Problem solved

Functional benefit

Products and services

  • Cytometry Platform

Quantifiable outcome

  • 10th consecutive ISO 9001:2015 certification achieved in June 2023, demonstrating sustained quality management over 10+ years
  • +3 more outcomes

Companies that use CarMeN Laboratory INRAE UMR1397-INSERM U1060

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

CarMeN Laboratory INRAE UMR1397-INSERM U1060 technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

CarMeN Laboratory INRAE UMR1397-INSERM U1060 partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered minor and core.

  • IHU EverestminorStrategic or Co-development Partner · 1 February 2025Institute hosting the symposium on Hepatic Organoids & Ex Vivo 3D Models organized by Jennifer Rieusset at Lyon Sud. Collaborative platform for liver research using organoid and 3D model technologies.
  • Federal University of Paraíba - BrazilminorStrategic or Co-development Partner · 1 November 2024Franco-Brazilian research collaboration through CAPES-COFECUB project coordinated by Prof. Marciane Magnani, partnering with Prof. Hubert Vidal on probiotic and prebiotic research.
  • Federal University of Pernambuco (UFPE) - BrazilminorStrategic or Co-development Partner · 1 October 2024Franco-Brazilian cooperation through CAPES-COFECUB project on translational evaluation of probiotics and prebiotics. Hosting of Prof. Carol Gois Leandro for collaborative seminar on VITORIA project (obesity reduction in adolescents).
  • Université Laval - CanadaminorOthers · 1 May 2024Hosted Prof. Benoît Arsenault for seminar on body weight and health research. Researcher at Institut de cardiologie et de pneumologie du Québec focusing on cardiometabolic risk markers and lifestyle modification interventions.
  • INSERM U1060coreStrategic or Co-development Partner · 1 January 2011Institut national de la santé et de la recherche médicale - primary institutional affiliation providing research framework, funding, and personnel oversight. Laboratory created at Lyon in January 2011 under this partnership and renewed in 2016 and January 2021.
  • INRAE U1397coreStrategic or Co-development Partner · 1 January 2011Institut national de recherche pour l'agriculture, l'alimentation et l'environnement - institutional partner co-managing the laboratory. Part of the joint INSERM U1060/INRAE U1397 structure.
  • Université Lyon 1 (Claude Bernard)coreStrategic or Co-development Partner · 1 January 2011Université Claude Bernard Lyon 1 - academic partner providing university framework, student training, and research supervision for doctoral programs.
  • Hospices Civils de LyoncoreStrategic or Co-development Partner · 1 January 2011Public hospital system hosting the laboratory at Lyon Sud Hospital and providing clinical research infrastructure and patient access for cardio-metabolic studies.
  • Centre de Recherche en Nutrition Humaine Rhône-Alpes (CRNH-RA)coreStrategic or Co-development PartnerClinical nutrition research platform integrated into the CarMeN laboratory structure, located at Lyon Sud Hospital. Conducts human nutrition studies with authorized clinical research protocols.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

CarMeN Laboratory INRAE UMR1397-INSERM U1060 competitors and assessment

Company assessment

Broad incumbents

  • Pasteur Institute: Major French non-profit biomedical research institution. Comparable to CarMeN's non-profit public research model, multi-platform structure, and translational publication record, though broader in scope.
  • Karolinska Institutet: Leading European medical university conducting biomedical and clinical research including metabolic disease. Comparable to CarMeN in academic research mission, publication output, and clinical-trial execution capability, though operating at much larger scale.
  • CNRS (Centre National de la Recherche Scientifique): France's largest public research organization. Comparable as a parent-equivalent public research framework operating under similar French institutional funding mechanisms and shared laboratory hosting arrangements.
  • Institut Necker-Enfants Malades (INEM, INSERM U1151): French INSERM biomedical research unit. Comparable as a French academic biomedical research organization operating under similar institutional frameworks and grant structures, though its focus is broader and less cardio-metabolic-centric.

Direct peers

  • MRC Metabolic Diseases Unit (University of Cambridge): UK-based academic unit focused on metabolic disease mechanisms, sharing CarMeN's cardio-metabolic research mandate and bench-to-clinic translation pathway.
  • Max Planck Institute for Metabolism Research: German research institute dedicated to metabolism, obesity, and diabetes research. Highly comparable to CarMeN given the overlapping cardio-metabolic disease focus and basic-to-translational research model, though operating at larger scale.
  • Institut de Cardiologie et de Pneumologie de Québec (IUCPQ): Canadian cardiovascular research center that hosted CarMeN's collaboration with Prof. Benoît Arsenault. Comparable given overlapping cardio-metabolic risk-marker research and lifestyle intervention clinical studies.
  • INRAE Centre for Human Nutrition Research: Parent-affiliated INRAE unit focused on nutrition research. Closely comparable as a French nutrition research organization sharing CarMeN's INRAE U1397 institutional framework and human nutrition methodology.
  • IHU Everest (Institut Hospitalo-Universitaire): French institute focused on liver and metabolic disease organoid/3D-model research. Direct peer given CarMeN's collaboration with IHU Everest on hepatic organoid research and overlapping MASLD/translational focus.

Emerging players

  • Nestlé Institute of Health Sciences: Industry-led nutrition and metabolic health research arm operating with similar cardio-metabolic and nutrition themes. Comparable to CarMeN's translational nutrition research scope but backed by private-sector funding rather than public grants.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

CarMeN Laboratory INRAE UMR1397-INSERM U1060 social profiles

Digital presence

CarMeN Laboratory INRAE UMR1397-INSERM U1060 compliance and trust

Trust signal

Compliance1 record

CarMeN Laboratory INRAE UMR1397-INSERM U1060 financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CarMeN Laboratory INRAE UMR1397-INSERM U1060 leadership team

Management profile

Number of profiles

Profiles7 records

CarMeN Laboratory INRAE UMR1397-INSERM U1060 subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

CarMeN Laboratory INRAE UMR1397-INSERM U1060 funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CarMeN Laboratory INRAE UMR1397-INSERM U1060 M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CarMeN Laboratory INRAE UMR1397-INSERM U1060

What does CarMeN Laboratory INRAE UMR1397-INSERM U1060 do?

CarMeN is a French biomedical research laboratory conducting fundamental and translational research on cardiovascular diseases, metabolism, diabetes, and nutrition. It operates three research teams (DO-IT, MERISM, IRIS) and provides access to six specialized technical platforms (cytometry, genomics, histology, Ixplora, microscopy, and biobank). The affiliated CRNH Rhône-Alpes clinical research platform conducts human nutrition studies and recruits volunteers, while the laboratory maintains ISO 9001:2015 certified quality management.

Is CarMeN Laboratory INRAE UMR1397-INSERM U1060 a public or private company?

CarMeN Laboratory INRAE UMR1397-INSERM U1060 is a private company. It is classified as state government owned and is currently operating.

When was CarMeN Laboratory INRAE UMR1397-INSERM U1060 founded?

CarMeN Laboratory INRAE UMR1397-INSERM U1060 was founded in 2011. It employs 51 to 100 people.

Where is CarMeN Laboratory INRAE UMR1397-INSERM U1060 based?

CarMeN Laboratory INRAE UMR1397-INSERM U1060 is headquartered in Pierre-Bénite, France, in the Europe region.

How does CarMeN Laboratory INRAE UMR1397-INSERM U1060 make money?

Two revenue lines are on record. Public Research Funding is the primary driver. The others are clinical Research Services.

Who are CarMeN Laboratory INRAE UMR1397-INSERM U1060's main competitors?

Broad incumbents on record are Pasteur Institute, Karolinska Institutet, CNRS (Centre National de la Recherche Scientifique) and Institut Necker-Enfants Malades (INEM, INSERM U1151). Direct peers are MRC Metabolic Diseases Unit (University of Cambridge), Max Planck Institute for Metabolism Research, Institut de Cardiologie et de Pneumologie de Québec (IUCPQ), INRAE Centre for Human Nutrition Research and IHU Everest (Institut Hospitalo-Universitaire). Nestlé Institute of Health Sciences is listed as an emerging player.

Does CarMeN Laboratory INRAE UMR1397-INSERM U1060 have an API?

No public API is recorded for CarMeN Laboratory INRAE UMR1397-INSERM U1060.

What industry is CarMeN Laboratory INRAE UMR1397-INSERM U1060 in?

CarMeN Laboratory INRAE UMR1397-INSERM U1060's product category is Biomedical Research Services. Its primary akta.pro industry code is HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales